Gentian Diagnostics ASA (GENT.OL)

NOK 39.0

(0.0%)

Gross Profit Summary of Gentian Diagnostics ASA

Gentian Diagnostics ASA's latest annual gross profit in 2023 was 69.44 Million NOK , up 20.07% from previous year.
Gentian Diagnostics ASA's latest quarterly gross profit in 2024 Q2 was 20.69 Million NOK , up 1.79% from previous quarter.
Gentian Diagnostics ASA reported a annual gross profit of 49 Million NOK in annual gross profit 2022, up 22.67% from previous year.
Gentian Diagnostics ASA reported a annual gross profit of 39.94 Million NOK in annual gross profit 2021, up 11.63% from previous year.
Gentian Diagnostics ASA reported a quarterly gross profit of 16 Million NOK for 2024 Q3, down -17.91% from previous quarter.
Gentian Diagnostics ASA reported a quarterly gross profit of 20.32 Million NOK for 2024 Q1, up 39.74% from previous quarter.

Annual Gross Profit Chart of Gentian Diagnostics ASA (2023 - 2013)

Historical Annual Gross Profit of Gentian Diagnostics ASA (2023 - 2013)

Year	Gross Profit	Gross Profit Growth
2023	69.44 Million NOK	20.07%
2022	49 Million NOK	22.67%
2021	39.94 Million NOK	11.63%
2020	35.78 Million NOK	59.01%
2019	22.5 Million NOK	-43.05%
2018	39.51 Million NOK	35.33%
2017	29.2 Million NOK	22.29%
2016	23.87 Million NOK	15.69%
2015	20.64 Million NOK	5.62%
2014	19.54 Million NOK	9.95%
2013	17.77 Million NOK	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	20.69 Million NOK	1.79%
2024 Q3	16 Million NOK	-17.91%
2024 Q1	20.32 Million NOK	39.74%
2023 Q4	14.54 Million NOK	-12.49%
2023 FY	58.83 Million NOK	20.07%
2023 Q1	16.42 Million NOK	16.78%
2023 Q3	16.62 Million NOK	-13.8%
2023 Q2	19.28 Million NOK	17.44%
2022 Q3	10.29 Million NOK	-34.47%
2022 Q1	8.94 Million NOK	-19.95%
2022 FY	49 Million NOK	22.67%
2022 Q4	14.06 Million NOK	36.66%
2022 Q2	15.7 Million NOK	75.52%
2021 Q3	6.4 Million NOK	-51.44%
2021 FY	39.94 Million NOK	11.63%
2021 Q2	13.18 Million NOK	-13.38%
2021 Q1	15.22 Million NOK	361.28%
2021 Q4	11.17 Million NOK	74.5%
2020 Q2	14.2 Million NOK	53.28%
2020 Q1	9.27 Million NOK	1395.16%
2020 FY	35.78 Million NOK	59.01%
2020 Q4	3.3 Million NOK	-63.33%
2020 Q3	9 Million NOK	-36.65%
2019 FY	22.5 Million NOK	-43.05%
2019 Q4	620 Thousand NOK	-92.57%
2019 Q3	8.34 Million NOK	15.96%
2019 Q1	6.34 Million NOK	2.7%
2019 Q2	7.19 Million NOK	13.53%
2018 Q4	6.17 Million NOK	-60.3%
2018 FY	39.51 Million NOK	35.33%
2018 Q1	8.63 Million NOK	36.8%
2018 Q2	9.15 Million NOK	6.02%
2018 Q3	15.54 Million NOK	69.76%
2017 Q4	6.31 Million NOK	0.93%
2017 Q2	9.97 Million NOK	50.05%
2017 Q1	6.65 Million NOK	-24.7%
2017 FY	29.2 Million NOK	22.29%
2017 Q3	6.25 Million NOK	-37.29%
2016 Q4	8.83 Million NOK	114.61%
2016 Q2	5.48 Million NOK	-3.41%
2016 Q1	5.68 Million NOK	9.07%
2016 FY	23.87 Million NOK	15.69%
2016 Q3	4.11 Million NOK	-25.02%
2015 FY	20.64 Million NOK	5.62%
2015 Q3	4.77 Million NOK	0.0%
2015 Q4	5.2 Million NOK	9.03%
2014 FY	19.54 Million NOK	9.95%
2013 FY	17.77 Million NOK	0.0%

Peer Gross Profit Comparison of Gentian Diagnostics ASA

Name	Gross Profit	Gross Profit Difference
Lifecare AS	11.56 Million NOK	-500.705%
Medistim ASA	222.57 Million NOK	68.8%